Mark J. Daniel
Chief Financial Officer
CFO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Atossa Therapeutics, Inc. (ATOS) | — | $72,516 | $536,489 |
Earnings-call appearances
No earnings-call appearances recorded yet.